| Common Stock, Shares Authorized |
500,000,000 |
shares |
|
Q2 2025 |
Q2 2025 |
| Common Stock, Shares, Issued |
169,110,000 |
shares |
|
Q2 2025 |
Q2 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q2 2025 |
Q2 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$348,153 |
USD |
|
Q2 2025 |
Q2 2025 |
| Deferred Tax Assets, Valuation Allowance |
¥68,170,911 |
CNY |
|
Q2 2025 |
Q2 2025 |
| Operating Lease, Liability |
¥1,106,201 |
CNY |
|
Q2 2025 |
Q2 2025 |
| Lessee, Operating Lease, Liability, to be Paid |
¥1,186,574 |
CNY |
|
Q2 2025 |
Q2 2025 |
| Operating Lease, Liability, Current |
$122,146 |
USD |
|
Q2 2025 |
Q2 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
¥739,703 |
CNY |
-74% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
¥697,131 |
CNY |
|
Q2 2025 |
Q2 2025 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.03 |
pure |
0% |
Q2 2025 |
Q2 2025 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
¥80,373 |
CNY |
|
Q2 2025 |
Q2 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
¥58,992,199 |
CNY |
|
Q2 2025 |
Q2 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
¥490,538 |
CNY |
-96% |
Q4 2024 |
FY 2024 |